Viewing nowDapagliflozin Propanediol Hydrate 5 mg Tablet
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Aprogen Pharmaceuticals Co., Ltd.

MFDS item code 202200836 · Approved 2022.02.23 · Insurance code 645210630
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to help control blood sugar for patients with type 2 diabetes. It can be taken alone or in combination with other medications, alongside dietary and exercise therapy. This medication can be particularly beneficial for patients who have difficulty controlling blood sugar and have cardiovascular disease or risk factors. Therefore, this medication is used to improve blood sugar control and prevent cardiovascular complications in type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and as add-on therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be administered to certain patients. For example, patients allergic to this medication's active ingredient or excipients, type 1 diabetes patients, patients with diabetic ketoacidosis, and those undergoing dialysis should not use this medication. This medication should be used cautiously in patients with reduced fluid volume or impaired kidney function. It may lower blood pressure or temporarily worsen kidney function, so fluid status and kidney function should be evaluated before administration, and periodic monitoring should be conducted during treatment. The blood sugar control effect of this medication may decrease in patients with moderate to severe kidney impairment, and it is not recommended for patients with severe kidney dysfunction. During the use of this medication, the risk of genital infections and urinary tract infections may increase, so patients should consult a healthcare professional immediately if any symptoms of infection occur. When used in combination with insulin or sulfonylureas, which have a risk of hypoglycemia, caution should be taken for signs of hypoglycemia, and the dosage of those medications should be adjusted if necessary. This medication may cause side effects related to reduced fluid volume; therefore, patients should inform their healthcare provider immediately if they experience symptoms of dehydration or low blood pressure, and medications may need to be temporarily discontinued if necessary. Severe metabolic disorders such as diabetic ketoacidosis may occur, so if symptoms like nausea, vomiting, abdominal pain, or difficulty breathing appear, the patient should visit the hospital immediately. Women who are pregnant or planning to become pregnant are advised not to use this medication, and it should be discontinued immediately if pregnancy is confirmed. It is also considered safe for breastfeeding women not to take this medication. Elderly patients should be monitored more closely because they have a higher risk of changes in kidney function and reduced fluid volume. During the use of this medication, glucose may be detected in urine tests, so it is advisable to use different tests to evaluate blood sugar control. There is no specific antidote for overdose, so receiving appropriate treatment based on symptoms is important. This medication does not significantly affect driving or machine operation, but caution is necessary when used with drugs that carry a risk of hypoglycemia. Finally, the safety and efficacy of this medication in children have not been established, so it should not be used.
Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, decreased renal creatinine clearance at the start of treatment, dyslipidemia, elevated serum creatinine at the start of treatment, increased blood urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory disturbances, cerebral infarction, nerve compression, acute pyelonephritis, chest pain, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste disturbances, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, herpes zoster, sinusitis, tonsillitis, diverticulitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like symptoms, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, discomfort in the vulva, menstrual irregularities, itching, hives, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Yellow round film-coated tablet
Bottle - 28 tablets/bottle [Bottle: HDPE/Caps: PP], Bottle - 30 tablets/bottle [Bottle: HDPE/Caps: PP], Box - 28 tablets/box [7 tablets/Alu-Alu*4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Aprogen Pharmaceuticals Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.